Literature DB >> 1829137

Visuospatial cognition in Huntington's disease.

E Mohr1, P Brouwers, J J Claus, U M Mann, P Fedio, T N Chase.   

Abstract

The notion of specificity of visuospatial dysfunction in Huntington's disease (HD) was evaluated in a sample of afflicted patients as a function of symptom duration, age at onset, and overall dementia severity. Factor analytic procedures indicated that overall visuospatial processing capacity (factor 1) as well as the ability for spatial manipulation (factor 3) was markedly affected in HD patients. In contrast, consistency of spatial judgment (factor 2) appeared to remain relatively intact in these patients. Age at onset seemed to have no relationship with any of these variables, whereas dementia severity demonstrated a significant relationship with overall visuospatial processing capacity. Most importantly, duration of symptoms was significantly associated with the declining ability to mentally perform spatial manipulations. The observation of circumscribed visuospatial impairment in HD patients may have important consequences for the further understanding of the neurobehavioral consequences of this disorder.

Entities:  

Mesh:

Year:  1991        PMID: 1829137     DOI: 10.1002/mds.870060207

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  14 in total

1.  Intelligence indices in people with a high/low risk for developing Huntington's disease.

Authors:  G M de Boo; A Tibben; J B Lanser; A Jennekens-Schinkel; J Hermans; M Vegter-van der Vlis; R A Roos
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

Review 2.  Impairment of visuospatial function in idiopathic spasmodic torticollis.

Authors:  P Hinse; B Leplow; T Humbert; U Lamparter; A Junge; T Emskötter
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

Review 3.  Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease.

Authors:  Ashok N Hegde; Sudarshan C Upadhya
Journal:  Biochim Biophys Acta       Date:  2010-08-03

4.  Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation.

Authors:  L A Lione; R J Carter; M J Hunt; G P Bates; A J Morton; S B Dunnett
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

5.  Differential impairment of spatial location memory in Huntington's disease.

Authors:  J Brandt; B Shpritz; C A Munro; L Marsh; A Rosenblatt
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11       Impact factor: 10.154

6.  Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation.

Authors:  K P Murphy; R J Carter; L A Lione; L Mangiarini; A Mahal; G P Bates; S B Dunnett; A J Morton
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

7.  Does the Clock Drawing Test have focal neuroanatomical correlates?

Authors:  Daniel Tranel; David Rudrauf; Eduardo P M Vianna; Hanna Damasio
Journal:  Neuropsychology       Date:  2008-09       Impact factor: 3.295

Review 8.  Differential diagnosis of the major progressive dementias and depression in middle and late adulthood: a summary of the literature of the early 1990s.

Authors:  L D Rosenstein
Journal:  Neuropsychol Rev       Date:  1998-09       Impact factor: 7.444

9.  Visual perception in prediagnostic and early stage Huntington's disease.

Authors:  Brian F O'Donnell; Tanya M Blekher; Marjorie Weaver; Kerry M White; Jeanine Marshall; Xabier Beristain; Julie C Stout; Jacqueline Gray; Joanne M Wojcieszek; Tatiana M Foroud
Journal:  J Int Neuropsychol Soc       Date:  2008-05       Impact factor: 2.892

10.  PRECREST: a phase II prevention and biomarker trial of creatine in at-risk Huntington disease.

Authors:  Herminia D Rosas; Gheorghe Doros; Sona Gevorkian; Keith Malarick; Martin Reuter; Jean-Philippe Coutu; Tyler D Triggs; Paul J Wilkens; Wayne Matson; David H Salat; Steven M Hersch
Journal:  Neurology       Date:  2014-02-07       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.